In today’s recent session, 2.05 million shares of the Cadrenal Therapeutics Inc (NASDAQ:CVKD) have been traded, and its beta is 1.51. Most recently the company’s share price was $0.39, and it changed around -$0.01 or -3.04% from the last close, which brings the market valuation of the company to $6.28M. CVKD at last check was trading at a discount to its 52-week high of $2.17, offering almost -456.41% off that amount. The share price’s 52-week low was $0.36, which indicates that the recent value has risen by an impressive 7.69% since then. We note from Cadrenal Therapeutics Inc’s average daily trading volume that its 10-day average is 42560.0 shares, with the 3-month average coming to 84.34K.
Cadrenal Therapeutics Inc (NASDAQ:CVKD) trade information
Instantly CVKD has been showing red trend so far today with a performance of -3.04% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4474 on recent trading dayincreased the stock’s daily price by 12.83%. The company’s shares are currently down -46.95% year-to-date, but still down -9.79% over the last five days. On the other hand, Cadrenal Therapeutics Inc (NASDAQ:CVKD) is -15.92% down in the 30-day period. We can see from the shorts that 29256.0 shares have been sold at a short interest cover period of 0.38 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cadrenal Therapeutics Inc (CVKD) estimates and forecasts
Cadrenal Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -71.76 percent over the past six months and at a 34.55% annual growth rate that is well above the industry average of 16.30%.
CVKD Dividends
Cadrenal Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-May-09.
Cadrenal Therapeutics Inc (NASDAQ:CVKD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 46.72% of Cadrenal Therapeutics Inc shares, and 10.61% of them are in the hands of institutional investors. The stock currently has a share float of 19.91%.
